• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-

Return to search Page to restart search Return to Orphan Designation Search Page Return to Search Page
 
Generic Name:  treprostinil
Trade Name:  Remodulin
Date Designated:  06/04/1997
Orphan Designation:  Treatment of pulmonary arterial hypertension.
Orphan Designation Status:  Designated/Approved
FDA Orphan Approval Status:  Approved for Orphan Indication
Approved Labeled Indication: Treatment of pulmonary arterial hypertension. 
Marketing Approval Date:  05/21/2002
Exclusivity End Date:  05/21/2009
United Therapeutics Corp.
55 T.W. Alexander Dr.
Research Triangle Park, North Carolina 27709

The sponsor address listed is the last reported by the sponsor to OOPD.

-
-